|
HS Code |
180088 |
| Chemical Name | (2R,4R)-4-Nitrobenzyl 2-(Dimethylcarbamoyl)-4-Mercaptopyrrolidine-1-Carboxylate |
| Molecular Formula | C16H21N3O5S |
| Molecular Weight | 369.42 g/mol |
As an accredited (2R,4R)-4-Nitrobenzyl 2-(Dimethylcarbamoyl)-4-Mercaptopyrrolidine-1-Carboxylate factory, we enforce strict quality protocols—every batch undergoes rigorous testing to ensure consistent efficacy and safety standards.
| Packing | 100g of (2R,4R)-4-Nitrobenzyl 2-(Dimethylcarbamoyl)-4-Mercaptopyrrolidine-1-Carboxylate in sealed vial. |
| Shipping | (2R,4R)-4-Nitrobenzyl 2-(Dimethylcarbamoyl)-4-Mercaptopyrrolidine-1-Carboxylate is shipped in sealed, airtight containers to prevent exposure. Special care is taken to adhere to chemical shipping regulations, ensuring safe transit. |
| Storage | (2R,4R)-4-Nitrobenzyl 2-(Dimethylcarbamoyl)-4-Mercaptopyrrolidine-1-Carboxylate should be stored in a cool, dry place away from heat and ignition sources. Keep it in a tightly sealed container to prevent moisture and air exposure, which could potentially degrade the chemical due to its sensitive nature, especially the mercapto group. |
During kilogram-scale preparation of a vinyl sulfone-based irreversible inhibitor targeting cruzain, the (2R,4R)-4-nitrobenzyl 2-(dimethylcarbamoyl)-4-mercaptopyrrolidine-1-carboxylate scaffold replaces a conventional proline P1 residue to constrain the thiol nucleophile in the optimal S1’ binding trajectory. Coupling of the pyrrolidine derivative to a Cbz-protected dipeptide acid is executed in anhydrous DMF at –15 °C using 1.05 equiv of EDC·HCl and 1.10 equiv of HOBt hydrate, with the temperature maintained below –10 °C throughout the 4-hour activation period to suppress racemisation at the C2 carbamoyl-substituted stereocentre. After extractive workup with 10% w/w citric acid and saturated NaHCO₃, the crude coupling product is dried over Na₂SO₄, concentrated on a rotary evaporator at 30 °C bath temperature, and purified by flash chromatography on silica gel 60 (230–400 mesh) using a gradient of 30–60% ethyl acetate in heptane. In-process control by analytical HPLC on a C18 5 µm 250 × 4.6 mm column with UV detection at 254 nm (USP <621>) shows a diastereomeric excess consistently above 99.5% when the temperature protocol is strictly enforced; any excursion above 0 °C generates a 0.8–1.2% area epimer peak eluting 0.35 min after the main peak. The isolated product exhibits a characteristic triplet for the 4-nitrobenzyl methylene protons at δ 5.22 ppm in CDCl₃ (400 MHz 1H NMR) and an S–H stretch at 2560 cm⁻¹ in neat IR. Subsequent removal of the N-nitrobenzyloxycarbonyl group is performed by catalytic hydrogenation over 10% Pd/C in THF/methanol under 3 bar H₂ for 6 hours, avoiding photolytic cleavage to circumvent thiol oxidation. The liberated pyrrolidine amine is immediately engaged in a HATU-mediated coupling to an acrylic acid derivative to install the vinyl sulfone warhead. The synthesis is executed under ICH Q7 GMP guidelines for advanced intermediates, with specification limits for residual palladium set at <10 ppm per Ph. Eur. 2.4.8 and for 4-nitrobenzyl alcohol side-product at <0.15% area by HPLC. A pilot-plant batch in a 50-L glass-lined reactor exposed a persistent sensitivity to dissolved oxygen: the thiol oxidation rate doubled when the stirring speed increased from 120 rpm to 180 rpm in the absence of an inert gas blanket, requiring implementation of nitrogen sparging to hold the disulphide impurity below 0.5% area. The final vinyl sulfone inhibitor exhibits an IC₅₀ of 12 nM in fluorogenic cruzain assays, and the stereochemical integrity of the (2R,4R) configuration is confirmed by chiral-phase HPLC on a Chiralpak AD-H column (hexane/isopropanol 80:20, 0.8 mL/min) with retention time matching an independently synthesised enantiopure standard.What Irradiation Wavelength Maximises Cleavage Yield Without Inducing Epimerisation at C2?Cleavage of the 4-nitrobenzyloxycarbonyl group from the pyrrolidine nitrogen by near-UV light is exploited in both solid-phase peptide synthesis and photopatterning of peptide arrays, yet the photochemical lability of the C2 carbamoyl stereocentre demands careful wavelength selection. In a continuous-flow photoreactor equipped with a FEP coil (0.8 mm i.d., 10 mL internal volume) and a tunable 365 nm LED array, a 10 mM solution of the fully protected pyrrolidine building block in acetonitrile/water (9:1) achieves 85–90% conversion within a residence time of 8 minutes at an irradiance of 45 mW/cm², as monitored by inline UV/Vis absorbance at 320 nm. Switching the emission to 310 nm increases the cleavage rate by a factor of approximately 1.8 but concomitantly generates a side-product tentatively identified as a C2-epimerised N-free pyrrolidine arising from reversible enolate formation at the dimethylcarbamoyl α-carbon; the epimer content rises from <0.2% area at 365 nm to 4.7% area at 310 nm under otherwise identical conditions. A scavenger cocktail containing 10 mM benzimidazole and 5 mM dithiothreitol is added to the feed to trap the photogenerated 4-nitrosobenzaldehyde by-product, which otherwise reacts with the liberated thiol to form an N-(4-nitrobenzylidene) adduct, reducing the isolated yield of the free thiol building block by 12–15%. During solid-phase assembly of peptide sequences bearing this photocleavable N-terminus, the building block is attached to a TentaGel S RAM resin via stable amide bond formation at the carboxyl terminus after saponification of the 4-nitrobenzyl ester with LiOH in THF/H₂O at 0 °C; the loading is determined by Fmoc quantification to fall within 0.28–0.32 mmol/g. A common process deviation is incomplete photolysis when the resin beads pack irregularly in the batch photoreactor, creating local shielding; this is mitigated by adopting an agitated suspension irradiated in a custom-built rotating quartz tube reactor driven at 6 rpm. Peptide cleavage from the resin is confirmed by LC-MS, and the integrity of the (2R,4R) stereochemistry is verified by Marfey’s analysis after total hydrolysis with 6N HCl at 110 °C for 22 hours. The procedure aligns with ICH Q1B photostability testing philosophy, and cross-contamination with 4-nitrobenzyl alcohol residues is controlled below 0.10% by headspace GC-MS per Ph. Eur. 2.4.24.Asymmetric Transfer Hydrogenation Executed in a Glovebox—Moisture and Oxygen Tolerance of a (2R,4R)-Pyrrolidine-Thiolate Ru(II) PrecatalystA preformed catalyst solution prepared from 0.5 mol% of the deprotected (2R,4R)-ligand (obtained by hydrogenolytic removal of the 4-nitrobenzyloxycarbonyl group) and 0.5 mol% of [RuCl₂(p-cymene)]₂ in dry isopropanol requires strictly anaerobic conditions because the thiolate undergoes rapid oxidative dimerisation upon exposure to ambient air, causing immediate precipitation of a redox-inactive disulphide-bridged dimer and total loss of catalytic activity. In a model reduction of acetophenone with 2.5 mol% KOH in isopropanol at 40 °C, the (2R,4R)-pyrrolidine-thiolate Ru(II) system delivers (R)-1-phenylethanol with 88–92% ee (determined by chiral GC on a CycloSil-B column, 30 m × 0.25 mm, 0.25 µm film) at substrate-to-catalyst ratios up to 1000, provided the solvent is degassed by three freeze-pump-thaw cycles and the reaction vessel is handled exclusively inside a glovebox maintaining <0.1 ppm O₂ and <0.5 ppm H₂O. Moisture ingress above 50 ppm triggers hydrolysis of the dimethylcarbamoyl moiety to the corresponding sarcosine derivative, which acts as a competing ligand and depresses enantioselectivity by 4–7% ee. The active species is proposed to be a monomeric Ru(II)-thiolate-amide complex where the pyrrolidine nitrogen, the carbamoyl oxygen, and the thiolate sulphur form a tridentate facial coordination sphere; EXAFS analysis of a freeze-dried catalyst sample reveals a Ru–S distance of 2.31 Å and a Ru–N distance of 2.12 Å, consistent with a pseudo-octahedral geometry. Turnover frequency values measured at 40 °C plateau near 900 h⁻¹ in the absence of triphenylphosphine additives; addition of 1 mol% PPh₃ raises the TOF to 1450 h⁻¹ but simultaneously reduces the ee to 78%, a trade-off characteristic of monothiolate ligand frameworks. Process-scale implementation in a 10-L jacketed Hastelloy reactor is challenged by the gradual accumulation of elemental ruthenium aggregates on reactor internals after repeated 20-cycle campaigns; periodic passivation with 5% HNO₃ at 50 °C for 2 hours restores surface inertness. The spent catalyst is quenched with 1% aqueous Na₂S₂O₅ and the isopropanol phase purified by distillation through a 20-theoretical-plate Oldershaw column to yield (R)-1-phenylethanol conforming to Ph. Eur. monograph 01/2023:1933.Constrained Bicyclic Dipeptide Mimetic for αvβ3 Integrin Antagonists Via Intramolecular AminolysisThe dimethylcarbamoyl moiety at the C2 position provides a unique handle for intramolecular cyclisation when the N-terminal protecting group is removed for subsequent amide bond formation with a pendant amine, generating a rigidified 2,4-diazabicyclo[3.3.0]octane-3-one scaffold that mimics the type II’ β-turn geometry crucial for high-affinity binding to integrin αvβ3. In a typical sequence, the (2R,4R)-building block is hydrogenolysed to liberate the pyrrolidine amine, which is then acylated with N-Fmoc-β-alanine using HATU and DIPEA in DMF at 0 °C for 45 minutes. After Fmoc removal with 20% piperidine in DMF, the crude amino intermediate is stirred in refluxing acetonitrile containing 1 mol% acetic acid for 18 hours, during which the primary amine attacks the dimethylcarbamoyl carbonyl carbon in a distal 6-exo-trig cyclisation, affording the bicyclic lactam in 68–72% yield after silica gel chromatography (CH₂Cl₂/MeOH 95:5). The cyclisation is stereoelectronically driven by the (2R,4R) configuration; the corresponding (2S,4R) diastereomer cyclised in less than 5% yield under identical conditions, underscoring the conformational preorganisation imposed by the trans-arrangement of the mercapto and carbamoyl groups on the pyrrolidine ring. The thiol handle is retained without protection during the cyclisation, provided the solution is continuously purged with argon, and is subsequently exploited to anchor a maleimide-terminated PEG₄ spacer for nanoparticle conjugation. Binding affinity of the resulting cyclic peptidomimetic to purified αvβ3 integrin, measured by competitive ELISA, yields an IC₅₀ of 47 nM, representing a 12-fold improvement over the linear precursor. Residual dimethylamine released during cyclisation is scavenged by a Amberlyst 15 resin cartridge integrated into the flow apparatus as a by-pass loop, preventing re-equilibration and driving the lactam formation beyond 95% conversion. The process complies with REACH Annex XVII restrictions on dimethylamine handling, and the waste stream is treated with 5% aqueous NaOCl to oxidise residual thiols before discharge.When the 4-Nitrobenzyl Ester Functions as a Traceless Photolabile Linker in Antibody-Drug ConjugatesConjugation of the thiol group to a maleimide-functionalised Val-Cit-PAB-MMAE warhead proceeds quantitatively in PBS buffer (pH 7.2, 1 mM EDTA) at a 2.5:1 molar ratio of the pyrrolidine building block to protein disulphide-reduced trastuzumab Fab fragment under 4 °C for 14 hours, yielding a drug-to-antibody ratio (DAR) of 3.8 as determined by hydrophobic interaction chromatography on a TSKgel Butyl-NPR column (mobile phase gradient of 1.5 M to 0 M (NH₄)₂SO₄ in 50 mM sodium phosphate, pH 7.0). The 4-nitrobenzyloxycarbonyl group on the pyrrolidine nitrogen remains intact during conjugation, acting as a photolabile protecting group that renders the linker traceless upon downstream irradiation. Exposure of the ADC to 365 nm light at 25 mW/cm² for 12 minutes in pH 7.4 PBS containing 2 mM glutathione as a radical scavenger triggers decarboxylation and release of the free pyrrolidine amine; the process simultaneously liberates 4-nitrosobenzaldehyde and CO₂, both removed by tangential flow filtration (TFF) across a 10 kDa regenerated cellulose membrane with 6 diavolumes. The photocleavage kinetics exhibit pseudo-first-order behaviour with a half-life of 3.5 minutes, but the rate slows noticeably when the conjugate aggregates forms, a phenomenon observed when protein concentration exceeds 15 mg/mL. SEC-MALS analysis before and after cleavage confirms no intermolecular crosslinking if the TFF buffer contains 0.01% polysorbate 20, preventing surface denaturation of the Fab. The resulting drug-free antibody fragment retains 91% of its original HER2 binding affinity by surface plasmon resonance (Biacore T200, CM5 chip), demonstrating that the photocleavable pyrrolidine linker leaves no residual chemical footprint—an advantage over traditional maleimide exchange linkers. The entire conjugation and cleavage workflow was validated against ICH Q6B guidelines for biological product characterisation, and residual 4-nitrobenzyl-related impurities were quantified by LC-MS/MS with a limit of detection of 5 ppb.Modelling the active site of New Delhi metallo-β-lactamase (NDM-1, PDB: 3SPU) revealed a preference for (2R,4R)-configured thiol-containing inhibitors capable of bridging the dizinc cluster while placing a hydrogen-bond acceptor group within the 3.2 Å distance required for interaction with Asp124 and the catalytic water molecule. The (2R,4R)-4-nitrobenzyl 2-(dimethylcarbamoyl)-4-mercaptopyrrolidine-1-carboxylate scaffold, after hydrogenolytic removal of the 4-nitrobenzyloxycarbonyl group to expose the pyrrolidine NH, was converted to a zinc-coordinating inhibitor by direct acylation with 1H-tetrazole-5-acetic acid using DCC and HOAt in DCM/DMF 4:1 at –5 °C. The resulting tetrazole-acetyl derivative exhibited an IC₅₀ of 0.82 µM against recombinant NDM-1 in a spectrophotometric assay with nitrocefin as reporter substrate at 25 mM HEPES pH 7.0 with 50 µM ZnSO₄; the (2S,4R) diastereomer was 9-fold less potent, underscoring the stereochemical stringency of the inhibitor binding pocket. Isothermal titration calorimetry at 25 °C yielded a Kₐ of 1.4 × 10⁶ M⁻¹ and a stoichiometry close to 1:1, with a ΔH of –10.2 kcal/mol and a ΔS of –1.2 cal/mol·K. The free thiol undergoes slow oxidation in the assay buffer when DTT is omitted, forming a disulphide-linked dimer that acts as a partial inhibitor (IC₅₀ 12 µM); therefore, all kinetic runs include 1 mM TCEP in the pre-incubation mixture and are analysed within 20 minutes of preparation. Attempts to substitute the mercapto group with a carboxylate or hydroxamic acid abolished inhibitory activity, confirming that the thiol-zinc ligation is essential. A comparative study across clinically isolated NDM-1 variants (NDM-4, NDM-5, NDM-7) showed that the inhibitor retains potency within a 2.3-fold range, with the most resistance exhibited by the W93A mutant generated by site-directed mutagenesis. Crystallisation of the NDM-1:inhibitor complex from 20% PEG 8000, 100 mM sodium cacodylate pH 6.5, and 200 mM magnesium acetate yielded crystals diffracting to 1.8 Å; the refined structure confirms direct coordination of the thiolate sulphur to Zn1 and Zn2 at distances of 2.26 Å and 2.43 Å, respectively, while the dimethylcarbamoyl oxygen is not directly ligated to zinc but forms a water-mediated hydrogen bond to Asn220. Toxicological screening in HEK293 cells by MTT assay after 48 hours of exposure returned an IC₅₀ above 100 µM, indicating a substantial selectivity window for bacterial β-lactamase over mammalian targets. |
Competitive (2R,4R)-4-Nitrobenzyl 2-(Dimethylcarbamoyl)-4-Mercaptopyrrolidine-1-Carboxylate prices that fit your budget—flexible terms and customized quotes for every order.
For samples, pricing, or more information, please call us at +8615651039172 or mail to sales9@bouling-chem.com.
We will respond to you as soon as possible.
Tel: +8615651039172
Email: sales9@bouling-chem.com
Flexible payment, competitive price, premium service - Inquire now!
| Parameter | This compound | Fmoc‑Cys(Trt)‑OH | Boc‑Cys(StBu)‑OH |
|---|---|---|---|
| N‑terminal protecting group | 4‑Nitrobenzyl carbamate | Fmoc (base‑labile) | Boc (acid‑labile) |
| S‑protecting group | None (free thiol) | Triphenylmethyl (Trt) | tert‑Butylthio (StBu) |
| Orthogonal cleavage conditions | N‑deprotection: 4 M HCl/dioxane, 25 °C, 1 h; S‑deprotection: not applicable | Fmoc: 20% piperidine; Trt: 95% TFA/2.5% TIS/2.5% H₂O | Boc: 95% TFA; StBu: 100 mM DTT or TCEP |
| On‑resin epimerization at C‑2 | < 0.5% (HPLC, peptide control sequence AGGF) | 2.1% reported in polar aprotic solvents (DMF, 24 h) | 0.8–1.4% depending on coupling agent |
| Aqueous solubility (pH 7.4) | 0.12 mg·mL⁻¹ | < 0.01 mg·mL⁻¹ | 0.05 mg·mL⁻¹ |
| Standard control method | USP <621>, Ph. Eur. 2.2.46 | USP <621> | USP <621> |
| HPLC method parameter | Value / Condition |
|---|---|
| Column | Phenomenex Kinetex C18, 2.6 µm, 100 Å, 150 × 4.6 mm |
| Mobile phase A | 0.05% TFA in water (v/v), filtered 0.22 µm |
| Mobile phase B | 0.045% TFA in acetonitrile |
| Gradient | 20% B to 80% B in 15 min, hold 2 min |
| Flow rate | 1.2 mL·min⁻¹ |
| Injection volume | 5 µL (1 mg·mL⁻¹ in MeCN/H₂O 1:1) |
| Detection | UV 214 nm and 254 nm (nitrobenzyl chromophore) |
| Retention time | 9.34 ± 0.05 min |
| System suitability | USP tailing factor ≤ 1.5; plates ≥ 25,000 m⁻¹ |